iRadimed
IRMD
64 hedge funds and large institutions have $73.7M invested in iRadimed in 2019 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 16 reducing their positions, and 13 closing their positions.
31% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 16
29% more capital invested
Capital invested by funds: $57.2M → $73.7M (+$16.5M)
2.47% more ownership
Funds ownership: 21.38% → 23.85% (+2.5%)
4% less funds holding
Funds holding: 67 → 64 (-3)
23% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCMC
RK Capital Management (Colorado)
Denver,
Colorado
|
+$3.4M |
| 2 |
RIM
Ranger Investment Management
Dallas,
Texas
|
+$1.9M |
| 3 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
+$1.34M |
| 4 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
+$1.34M |
| 5 |
SIM
Spark Investment Management
New York
|
+$680K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EI
EAM Investors
Solana Beach,
California
|
-$1.19M |
| 2 |
EGI
EAM Global Investors
Solana Beach,
California
|
-$1.17M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$433K |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$364K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$300K |
IRMD Hedge Fund Activity: Q1 2019 in Review
64 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q1 2019, worth a combined $73.7M — up 29% from $57.2M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of IRMD and 10 opened new positions — a net loss of 3 holders — while 16 trimmed existing stakes and 21 added.
The largest buyer was RK Capital Management (Colorado), opening a new position worth an estimated $3.4M. The largest seller was EAM Investors, cutting an estimated $1.19M.
- 64 institutional investors held iRadimed (IRMD) as of Q1 2019, down from 67 in Q4 2018.
- Funds reported $73.7M of iRadimed stock for Q1 2019, up 29% quarter-over-quarter.
- 10 funds opened new iRadimed positions in Q1 2019 and 13 closed out, a net change of -3 holders.
- The largest iRadimed buyer in Q1 2019 was RK Capital Management (Colorado), an estimated $3.4M added.
- The largest iRadimed seller in Q1 2019 was EAM Investors, an estimated $1.19M sold.
Based on aggregated 13F filings for Q1 2019.